Armata Pharmaceuticals, Inc. Common Stock (ARMP)
R&D Expenses
$7.59M
Quarterly · Period ending: · USD
ARMP R&D Expenses
Latest reported$7.59Mperiod ending
Latest reported$7.59Mperiod ending
ARMP Quarterly R&D Expenses ($0.00 → $7.59M)
Quarterly R&D Expenses
High-resolution chart · PNG
ARMP r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 7,586,000 | |
| 6,111,000 | |
| 6,070,000 | |
| 5,824,000 | |
| 6,394,000 | |
| 5,429,000 | |
| 8,450,000 | |
| 9,485,000 | |
| 8,475,000 | |
| 8,016,000 | |
| 7,928,000 | |
| 7,978,000 | |
| 8,259,000 | |
| 9,604,000 | |
| 9,569,000 | |
| 8,400,000 | |
| 9,020,000 | |
| 8,028,000 | |
| 4,814,000 | |
| 5,626,000 | |
| 5,225,000 | |
| 4,350,000 | |
| 4,980,000 | |
| 4,066,000 | |
| 2,648,000 | |
| 2,750,000 | |
| 1,668,000 | |
| 3,019,000 | |
| 3,076,000 | |
| 1,494,000 | |
| 1,375,000 | |
| 361,000 | |
| 1,692,000 | |
| 1,464,000 | |
| 1,090,000 | |
| -829,000 | |
| 1,130,000 | |
| 1,490,000 | |
| 802,000 | |
| 1,655,000 | |
| 1,241,000 | |
| 1,980,000 | |
| 1,215,000 | |
| 728,000 | |
| 1,077,000 | |
| 972,000 | |
| 1,118,000 | |
| 1,804,000 | |
| 1,876,000 | |
| 1,006,000 | |
| 1,143,000 | |
| 1,123,000 | |
| 3,595,000 | |
| 641,000 | |
| 1,515,000 | |
| 1,891,000 | |
| 2,120,000 | |
| 3,889,000 | |
| 3,192,000 | |
| 4,156,000 | |
| 3,946,000 | |
| 4,869,000 | |
| 3,874,000 | |
| 5,270,000 | |
| 3,696,000 | |
| 3,999,000 | |
| 3,123,000 | |
| 3,683,000 | |
| 3,677,000 | |
| 4,199,000 | |
| 4,653,000 | |
| 4,808,000 | |
| 4,539,000 | |
| 3,955,000 | |
| 4,268,000 | |
| 4,828,000 | |
| 4,237,000 | |
| 4,381,000 | |
| 3,947,000 | |
| 4,327,000 | |
| 4,542,000 | |
| 6,267,000 | |
| 7,684,000 | |
| 8,325,000 | |
| 9,039,000 | |
| 9,616,000 | |
| 8,899,000 | |
| 6,638,000 | |
| 6,393,000 | |
| 6,551,000 | |
| 4,505,000 | |
| 4,538,000 | |
| 3,718,000 | |
| 4,000,000 | |
| 3,600,000 | |
| 3,500,000 | |
| 3,200,000 | |
| 4,600,000 | |
| 2,900,000 | |
| 2,600,000 |